The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity

Neuropharmacology

Volumn 43, Issue 8, 2002, Pages 1199-1209

  Henry, S A ^a   Lehmann Masten, V ^a   Gasparini, F ^b   Geyer, M A ^a   Markou, A ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Glutamate; Phencyclidine; PPI; Startle

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; LY 314582; PHENCYCLIDINE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; TIME;

EID: 0036945935     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00332-5     Document Type: Article

References (48)

1. Allen R.M., Young S.J. Phencyclidine-induced psychosis. American Journal of Psychiatry. 135:1978;1081-1084.
2. Attarian S., Amalric M. Microinfusion of the metabotropic glutamate receptor agonist 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation in the rat. European Journal of Neuroscience. 9:1997;809-816.
3. Azkue J.J., Mateos J.M., Elezgarai I., Benitez R., Osorio A., Diez J., Bilbao A., Bidaurrazaga A., Grandes P. The metabotropic glutamate receptor subtype mGluR 2/3 is located at extrasynaptic loci in rat spinal dorsal horn synapses. Neuroscience Letters. 287:2000;236-238.
4. Bakshi V.P., Tricklebank M., Neijt H.C., Lehmann-Masten V., Geyer M.A. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats. Journal of Pharmacology and Experimental Therapeutics. 288:1999;643-652.
5. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia: Human and animal model studies. Archives of General Psychiatry. 47:1990;181-188.
6. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry. 49:1992;206-215.
7. Cadenhead K.S., Geyer M.A., Braff D.L. Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder. American Journal of Psychiatry. 150:1993;1862-1867.
8. Cartmell J., Monn J.A., Schoepp D.D. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. Journal of Pharmacology and Experimental Therapeutics. 291:1999;161-170.
9. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., Corsi M., Orzi F., Conquet F. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neuroscience. 4:2001;873-874.
10. Conn P.J., Patel J. The Metabotropic Glutamate Receptors. 1994;Humana Press, Totowa, New Jersey.
11. Conn P.J., Pin J-P. Pharmacology and functions of metabotropic glutamate receptors. Annual Review of Pharmacology and Toxicology. 37:1997;205-237.
12. Dulawa S.C., Geyer M.A. Psychopharmacology of prepulse inhibition in mice. Chinese Journal of Physiology. 39:1996;139-146.
13. Floeter M.K. Spinal motor control, reflexes, and locomotion. Zigmond M.J., Bloom F.E., Landis S.C., Roberts J.L., Squire L.R. Fundamental Neuroscience. 1999;889-912 Academic Press, San Diego.
14. Gasparini F., Lingenhohl K., Stoehr N., Flor P.J., Heinrich M., Vranesic I., Biollaz M., Allgeier H., Heckendorn R., Urwyler S., Varney M.A., Johnson E.C., Hess S.D., Rao S.P., Sacaan A.I., Santori E.M., Velicelebi G., Kuhn R. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology. 38:1999;1493-1503.
15. Geyer M.A., Paulus M.P. Multivariate analyses of locomotor and investigatory behavior in rodents. Ossenkopp K.P., Kavaliers M., Sanberg P.R. Measuring Movement and Locomotion: From Invertebrates to Humans. 1996;253-271 R. G. Landes, Austin, TX.
16. Geyer M.A., Russo P.V., Masten V.L. Multivariate assessment of locomotor behavior: Pharmacological and behavioral analyses. Pharmacology Biochemistry and Behavior. 25:1986;277-288.
17. Geyer M.A., Swerdlow N.R. Measurement of the startle response, prepulse inhibition, and habituation. Crawley J.N., Skolnick P. Current Protocols in Neuroscience. 1998;8 John Wiley & Sons, New York.
18. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Research Bulletin. 25:1990;485-498.
19. Goff D.C., Wine L. Glutamate in schizophrenia: clinical and research implications. Schizophrenia Research. 27:1997;157-168.
20. Grauer S.M., Marquis K.L. Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats. Psychopharmacology. 141:1999;405-412.
21. Henry S.A., Dulawa S.C., Conquet F., Geyer M.A. Severe disruption of prepulse inhibition (PPI) in mice lacking mGluR5. Society for Neuroscience Abstracts. 25:1999;449.
22. Ison J.R., Hoffman H.S. Reflex modification in the domain of startle: II. The anomalous history of a robust and ubiquitous phenomenon. Psychological Bulletin. 94:1983;3-17.
23. Kim J-H., Beeler J.A., Vezina P. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Neuropharmacology. 39:2000;1692-1699.
24. Kim J-H., Vezina P. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. Journal of Pharmacology and Experimental Therapeutics. 283:1997;962-968.
25. Krebs-Thomson K., Lehmann-Masten V., Naiem S., Paulus M.P., Geyer M.A. Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin. European Journal of Pharmacology. 343:1998;135-143.
26. Lehmann-Masten V.D., Geyer M.A. Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Neuropharmacology. 30:1991;629-636.
27. Lu Y.M., Jia Z., Janus C., Henderson J.T., Gerlai R., Wojtowicz J.M., Roder J.C. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. Journal of Neuroscience. 17:1997;5196-5205.
28. Lujan R., Nusser Z., Roberts J.D., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. European Journal of Neuroscience. 8:1996;1488-1500.
29. Mansbach R.S., Geyer M.A. Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat. Neuropsychopharmacology. 2:1989;299-308.
30. Moghaddam B., Adams B.W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 281:1998;1349-1352.
31. Monn J.A., Valli M.J., Massey S.M., Wright R.A., Salhoff C.R., Johnson B.G., Howe T., Alt C.A., Rhodes G.A., Robey R.L., Griffey K.R., Tizzano J.P., Kallman M.J., Helton D.R., Schoepp D.D. Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. Journal of Medicinal Chemistry. 40:1997;528-537.
32. Morita T., Sonoda R., Nakato K., Koshiya K., Wanibuchi F., Yamaguchi T. Phencyclidine-induced abnormal behaviors in rats as measured by the hole board apparatus. Psychopharmacology. 148:2000;281-288.
33. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
34. Neki A., Ohishi H., Kaneko T., Shigemoto R., Nakanishi S., Mizuno N. Pre- and postsynaptic localization of a metabotropic glutamate receptor, mGluR2, in the rat brain: an immunohistochemical study with a monoclonal antibody. Neuroscience Letters. 202:1996;197-200.
35. Ohishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience. 53:1993;1009-1018.
36. Ohishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. Journal of Comparative Neurology. 335:1993;252-266.
37. Petralia R.S., Wang Y.-X., Niedzielski A.S., Wenthold R.J. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience. 71:1996;949-976.
38. Pin J-P., Duvoisin R. The metabotropic glutamate receptors: Structure and functions. Neuropharmacology. 34:1995;1-26.
39. Schreiber R., Lowe D., Voerste A., De Vry J. LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine. European Journal of Pharmacology. 388:2000;R3-R4.
40. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. Journal of Neuroscience. 17:1997;7503-7522.
41. Sipes T.A., Geyer M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 33:1994;441-448.
42. Spooren W.P.J.M., Gasparini F., van der Putten H., Koller M., Nakanishi S., Kuhn R. Lack of effect of LY314582 (a group 2 metabotropic glutamate receptor agonist) on phencyclidine-induced locomotor activity in metabotropic glutamate receptor 2 knockout mice. European Journal of Pharmacology. 397:2000;R1-R2.
43. Sturgeon R.D., Fessler R.G., Meltzer H.Y. Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. European Journal of Pharmacology. 59:1979;169-179.
44. Swanson C.J., Kalivas P.W. Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. Journal of Pharmacology and Experimental Therapeutics. 292:2000;406-414.
45. Swanson L.W. Cerebral hemisphere regulation of motivated behavior. Brain Research. 886:2000;113-164.
46. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophrenia Bulletin. 24:1998;285-301.
47. Swerdlow N.R., Geyer M.A., Braff D.L. Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharmacology. 156:2001;194-215.
48. Testa C.M., Standaert D.G., Young A.B., Penney J.B. Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. Journal of Neuroscience. 14:1994;3005-3018.